Tag Archives: vertex

August, 2017

July, 2017

  • 19 July

    Vertex Announces Positive Results for Cystic Fibrosis Triple Combos

    BOSTON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced positive data from Phase 1 and Phase 2 studies of three different triple combination regimens in people with cystic fibrosis (CF) who have one F508del mutation and one minimal function mutation (F508del/Min). These are the first data to demonstrate the potential to treat the underlying …

May, 2017

March, 2017

December, 2016

October, 2016

August, 2016

  • 17 August

    Vertex to Stop of Experimental Cystic Fibrosis Phase 3 Combo Trial

    BOSTON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today provided an update on its ongoing Phase 3 development program of its investigational compound VX-661 in combination with ivacaftor, which includes four studies that together are expected to enroll more than 1,000 people with cystic fibrosis (CF). Based on a planned interim futility …

July, 2016

  • 6 July

    Vertex and Moderna Partner to Develop mRNA Therapeutics for Cystic Fibrosis

    BOSTON & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Moderna Therapeutics today announced that the two companies have entered into an exclusive research collaboration and licensing agreement aimed at the discovery and development of messenger Ribonucleic Acid (mRNA) Therapeutics™ for the treatment of cystic fibrosis (CF). The three-year collaboration …